Company · CIK 0001664106 · SIC 2836 — Biological Products, (No Diagnostic Substances)
LogicBio Therapeutics, Inc. · LOGC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2018 PForm 4 → | Oct 26, 9:29 am EDT | Arix Bioscience plc +110% Owner | 700,000 | $10.00 | $7,000,000 | 2,979,023 | +30.7% | plan? late |
| Oct 23, 2018 CForm 4 → | Oct 26, 9:29 am EDT | Arix Bioscience plc +110% Owner | 2,279,023 | — | — | 2,279,023 | — | plan? late |
| Oct 23, 2018 PForm 4 → | Oct 25, 6:28 pm EDT | ORBIMED ADVISORS LLC +3Director, 10% Owner | 1,190,000 | $10.00 | $11,900,000 | 6,466,783 | +22.6% | plan? |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:28 pm EDT | ORBIMED ADVISORS LLC +3Director, 10% Owner | 5,276,783 | — | — | 5,276,783 | — | plan? |
| Oct 23, 2018 PForm 4 → | Oct 25, 6:27 pm EDT | Tomer KarivDirector | 420,000 | $10.00 | $4,200,000 | 1,787,413 | +30.7% | plan? |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:27 pm EDT | Tomer KarivDirector | 1,367,413 | — | — | 1,367,413 | — | plan? |
| Oct 23, 2018 PForm 4 → | Oct 25, 6:25 pm EDT | Sofia IoannidouDirector | 420,000 | $10.00 | $4,200,000 | 1,787,413 | +30.7% | plan? |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:25 pm EDT | Sofia IoannidouDirector | 1,367,413 | — | — | 1,367,413 | — | plan? |
| Oct 23, 2018 PForm 4 → | Oct 25, 6:25 pm EDT | Daniel P O'ConnellDirector | 700,000 | $10.00 | $7,000,000 | 2,979,023 | +30.7% | plan? |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:25 pm EDT | Daniel P O'ConnellDirector | 2,279,023 | — | — | 2,279,023 | — | plan? |
| Oct 23, 2018 PForm 4 → | Oct 25, 6:24 pm EDT | Erez ChimovitsDirector | 490,000 | $10.00 | $4,900,000 | 3,487,760 | +16.3% | plan? |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:24 pm EDT | Erez ChimovitsDirector | 2,997,760 | — | — | 2,997,760 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2019 AForm 4 → | Feb 22, 5:10 pm EST | Kenneth HuttnerSVP, Head of Clinical Dev. | 50,818 | — | — | 50,818 | — | |
| Oct 23, 2018 CForm 4 → | Oct 26, 9:29 am EDT | Arix Bioscience plc +110% Owner | 4,352,775 | — | — | 0 | — | late |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:28 pm EDT | ORBIMED ADVISORS LLC +3Director, 10% Owner | 10,078,289 | — | — | 0 | — | |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:27 pm EDT | Tomer KarivDirector | 2,611,665 | — | — | 0 | — | |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:25 pm EDT | Sofia IoannidouDirector | 2,611,665 | — | — | 0 | — | |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:25 pm EDT | Daniel P O'ConnellDirector | 4,352,775 | — | — | 0 | — | |
| Oct 23, 2018 CForm 4 → | Oct 25, 6:24 pm EDT | Erez ChimovitsDirector | 5,725,514 | — | — | 0 | — | |
| Oct 18, 2018 AForm 4/A → | Oct 24, 5:03 pm EDT | Frederic ChereauPresident, CEO, Director | 155,000 | — | — | 155,000 | — | |
| Oct 18, 2018 AForm 4/A → | Oct 24, 5:03 pm EDT | Sandra PooleChief Operating Officer | 77,500 | — | — | 77,500 | — | |
| Oct 18, 2018 AForm 4/A → | Oct 24, 5:03 pm EDT | Matthias JaffeChief Financial Officer | 69,500 | — | — | 69,500 | — | |
| Oct 18, 2018 AForm 4/A → | Oct 24, 5:02 pm EDT | Dean FalbChief Scientific Officer | 30,000 | — | — | 30,000 | — | |
| Oct 18, 2018 AForm 4/A → | Oct 24, 5:01 pm EDT | Thomas WiltonChief Business Officer | 29,000 | — | — | 29,000 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:23 pm EDT | Daniel P O'ConnellDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:22 pm EDT | Sandra PooleChief Operating Officer | 106,262 | — | — | 106,262 | — | amended |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:20 pm EDT | Mark A KayDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:19 pm EDT | Erez ChimovitsDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:19 pm EDT | Leon ChenDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:17 pm EDT | Thomas WiltonChief Business Officer | 39,762 | — | — | 39,762 | — | amended |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:16 pm EDT | Sofia IoannidouDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:16 pm EDT | Dean FalbChief Scientific Officer | 41,134 | — | — | 41,134 | — | amended |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:15 pm EDT | Frederic ChereauPresident, CEO, Director | 212,525 | — | — | 212,525 | — | amended |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:13 pm EDT | Michael S WyzgaDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:13 pm EDT | Tomer KarivDirector | 24,102 | — | — | 24,102 | — | |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:12 pm EDT | Matthias JaffeChief Financial Officer | 95,293 | — | — | 95,293 | — | amended |
| Oct 18, 2018 AForm 4 → | Oct 22, 9:12 pm EDT | Richard A MoscickiDirector | 24,102 | — | — | 24,102 | — |